Memorial Sloan Kettering Commack
Commack, NY
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Accepting patients
NUTRIVENTION-4
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
Learn more- Monoclonal Antibody
- CD38
- Maintenance
- Phase 2
Accepting patients
Talquetamab Consolidation After BCMA CAR-T
Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- GPRC5D
- Post-CAR T
- Phase 2
Accepting patients
MagnetisMM-30
A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- BCMA
- CD3
- Phase 1
Accepting patients
Isatuximab After Allogeneic Stem Cell Transplant
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
Learn more- Monoclonal Antibody
- CD38
- Phase 2
Accepting patients
Melphalan With or Without Siltuximab
Phase II Randomized Trial of Population PK Dosed Melphalan With Interleukin-6 Blockade With Siltuximab Vesrus BSA Based Melphalan in Patients With Multiple Myeloma Over Age 60 Undergoing Autologous Stem Cell Transplantation
Learn more- Monoclonal Antibody
- Interleukin 6 (IL-6)
- Post-Autologous Stem Cell Transplant
- Pre-Autologous Stem Cell Transplant
- Phase 2
4 hidden based on your filters. Show All